Yesterday, Today and Tomorrow of Antibody Manjula Das, Principal Investigator, Mazumdar Shaw Center for Translational Research (MSCTR)
10:45
Q/A Discussion
10:50
Keynote Presentation
Cancer Immunotherapeutics: Combining the Basic and Translational Research Rajan Dighe, Professor, Indian Institute of Science
11:30
Q/A Discussion
11:35
Antibody Engineering in Biotherapeutic Development Ashvini Kumar Dubey, Senior Scientist, Zumutor Biologics
12:10
Q/A Discussion
12:15
AbTids - A New Class of Antimicrobials Sanjiban K Banerjee, Director, AbGenics Lifesciences Pvt Ltd
12:50
Q/A Discussion
12:55
Antibody Engineering Approach for High Quality Clone & Process Development Shailja Dwivedi, Sr. Research Executive- Advanced Biotech Lab, Ipca Laboratories Ltd
13:30
Q/A Discussion
13:35
Group Photograph Session
13:45
Lunch Break and Networking in Exhibition Area
Scientific Session II - ADC Development
14:45
Development of Site-Specific Steroid-ADC for the Treatment of Inflammatory Diseases Amy Han, Director, Chemistry, Regeneron Pharmaceuticals
15:20
Q/A Discussion
15:25
Next Generation Antibody Drug Conjugates (ADCs): Firing Magical Bullets Continues Syeda Warisul Fatima, Research Scholar, Indian Institute of Technology Delhi
15:35
Q/A Discussion
15:40
Coffee Break and Networking in Exhibition Area
16:10
Keynote Presentation
Dual Targeting Antibody-Drug Conjugates (ADCs) – Tumors and Their Vasculature Dimiter Stanchev Dimitrov, Professor, University of Pittsburgh
16:50
Q/A Discussion
16:55
Conference Feedback
17:00
End of First Day of Conference
Friday, 25 May 2018
Technical Session
09:01
Introduction to Technical Session
09:10
Developing Validated Assays for Biomarkers and Antibody Drug Conjugates Kalpesh Jain, Founder and Technical Head, KRISHGEN Biosystems
09:35
Q/A Discussion
09:40
Technology Spotlight: Glimpses of Solutions and Portfolio for Advanced Applications Ashish Pargaonkar, Field Applications Specialist - Biopharma
09:55
Technology Spotlight: iQue® Plus - Unique Among Flow-Cytometers Suyog Jakhadi, Product Manager- Bio-Analytics & Liquid Handling Products
10:10
Technology Spotlight: Antibody Engineering reducing Antibody Dilemma in Biomarkers Study Rashmi Upadhyay, Head- Sales & Marketing
10:25
Coffee Break and Networking in Exhibition Area
Scientific Session III - ADC Analysis
10:55
Steps in Designing an ADC Priyaranjan Pattanaik, Associate Research Director, Syngene International Ltd
11:30
Q/A Discussion
11:35
A Streamlined Drug-to-Antibody Ratio Determination Workflow for Intact and Deglycosylated Antibody-Drug Conjugates Ashish Pargaonkar, Field Applications Specialist - Biopharma, Agilent Technologies India Pvt Ltd.
12:10
Q/A Discussion
12:15
Interactive Session This is going to be a special designed interactive session wherein, the delegates will get an excellent opportunity to interact with the renowned experts/speakers in an informal open discussion giving them a chance to put up queries and get solutions.
12:55
Lunch Break and Networking in Exhibition Area
Scientific Session IV - Overcoming Challenges in Development of Successful ADCs
13:55
Keynote Presentation
Antibody-Drug Conjugates: Challenges in Translating Preclinical Success into Clinical Reality in Cancer Therapy Immunotherapy Nitin Damle, Senior Vice President and Head, Discovery Biology/ CSO, Sun Pharma Advanced Research Company Limited
14:35
Q/A Discussion
14:40
The Curious Case of T-DM1 – First Antibody Drug Conjugate for HER2 Positive Breast Cancer Jagdish Nigade, Group Medical Manager, Roche
15:15
Q/A Discussion
15:20
Coffee Break and Networking in Exhibition Area
15:50
Keynote Presentation
Antibody Drug Conjugates: Understanding the Intricacies of Design, Formulation and Product Manufacturing Satish Singh, Head, Lonza Inc